Replies to post #4689 on Fresenius Kabi Pharmaceuticals (APCVZ)

[cberg55110]

Yes this seems odd because the unusuals espense is in the 4th quarter fiscal quarter (which they go by) is January 31st. It is way out of the ordinary to because they had unusual expense in seond quarter for -4m, 3rd qourter of 53m then 341 million in fourth q. with a large deal with APP during the later end of the fourth quarter.